By Lawrence Elbaum and Patrick Gadson Few financial market frenzies have matched the intensity of last year’s boom in special purpose acquisition company (SPAC) mergers. SPACs — which raise capital […]

LOS ANGELES–(BUSINESS WIRE)–Surf Air Mobility Inc. announced today its confidential submission of a draft registration statement on Form S-1 with the Securities and Exchange Commission (the “SEC”) for a proposed […]

IPO Edge and the Palm Beach Hedge Fund Association will host a fireside chat with reAlpha on Wednesday Nov. 30 at 12 PM ET to discuss the company’s business model and points […]

By IPO Edge Editorial Staff OPAL Fuels Inc. (Nasdaq: OPAL), a producer and distributor of renewable natural gas (RNG), posted a surge in third-quarter revenue and issued full-year guidance. Revenue […]

Lifecore Biomedical CEO James G. Hall By Jarrett Banks IPO Edge: Can you give me a short description of what Lifecore does? Lifecore Biomedical is a fully integrated contract development […]

MALVERN, Pa.–(BUSINESS WIRE)–Ecovyst Inc. (NYSE: ECVT) (the “Company”) today announced the upsize and pricing of the previously announced underwritten public offering (the “Offering”) by funds affiliated with CCMP Capital Advisors, […]

IPO Edge and the Palm Beach Hedge Fund Association hosted a fireside chat with SatixFy and Endurance Acquisition Corp. (NASDAQ: EDNC) to discuss the role of SatixFy in Direct-to-Cell 5G Non-terrestrial networks and […]

By IPO Edge Editorial Staff DTC fashion brands portfolio a.k.a Brands Holding Corp. (NYSE: AKA) said active customers surged in a challenging environment. Active customers increased 23% on a last-twelve-month […]

Revenue increased to $26.0 million in the third quarter of 2022 Company raises revenue guidance to $85 million to $90 million for 2022 Sell-side advertising segment grew to $18.9 million […]

RADNOR, Pa.–(BUSINESS WIRE)–$MRNS #MarinusPharma–Marinus Pharmaceuticals, Inc. (Nasdaq: MRNS), a pharmaceutical company dedicated to the development of innovative therapeutics to treat seizure disorders, today announced the pricing of its underwritten public […]